NICOLE SMITH: Open Payments
NPI 1013590876 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,500 in 86 payments from 21 companies in 2025. Trend: 2023 $193 · 2024 $874 · 2025 $1,500
Food & beverage: $1,500
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $281 |
| Neurelis, Inc. | 13 | $184 |
| SERVIER PHARMACEUTICALS LLC | 6 | $109 |
| ARGENX US, INC. | 6 | $98 |
| Teva Pharmaceuticals USA, Inc. | 6 | $97 |
| TG Therapeutics, Inc. | 1 | $88 |
| Tanabe Pharma America, Inc. | 5 | $86 |
| SK Life Science, Inc. | 5 | $83 |
| Amneal Pharmaceuticals LLC | 4 | $72 |
| JAZZ PHARMACEUTICALS INC. | 4 | $67 |
Products named: VALTOCO, BRIUMVI, Radicava, Rystiggo, Briviact, CREXONT, Fintepla, EPIDIOLEX.
Industry payments across NJ — which companies pay providers there.
